InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Doctor Matthew, Vice-Président Exécutif, Directeur de la Stratégie. Officer active across 1 company, notably REGIS CORP. Aggregated, 9 disclosures have been logged. History available since 5 November 2021. The latest transaction was filed on 22 November 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Doctor Matthew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
16,500 股0Common StockSEC:0001415889-24-027765:0
547 股@ US$23.3712.8% 占其流量Common StockSEC:0001415889-24-027260:0
339 股@ US$23.378.0% 占其流量Common StockSEC:0001415889-24-026379:0
211 股@ US$12.352.6% 占其流量Common StockSEC:0000716643-24-000010:0
3,648 股@ US$0.532.0% 占其流量Common StockSEC:0000716643-23-000048:0
2,837 股@ US$1.263.9% 占其流量Common StockSEC:0000716643-22-000090:0
4,343 股@ US$1.6510.0% 占其流量Common StockSEC:0000716643-22-000020:0
46,344 股0Common StockSEC:0001179110-21-010175:0
12,234 股@ US$2.7646.9% 占其流量Common StockSEC:0000716643-21-000084:0
9 条申报中的 9 条
About Doctor Matthew
Doctor Matthew is Executive Vice President, Chief Strategy Officer. The record shows 9 filings in total, and the 9 sampled filings cover the period from 2021-11-09 to 2024-11-26. The buy and sell amounts shown for these recent filings are 0 EUR each, and the most frequent transaction nature is Tax withholding.
